Skip to content

Ayahuasca's antidepressant effects covary with behavioral activation as well as mindfulness

Maha N. Mian

2019 DOI: 10.54014/1c38-bn99 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional survey Placebo-controlled
Sample size 152
Population Individuals who had an ayahuasca experience
Intervention Ayahuasca
Topics Anxiety Ayahuasca Meditation
Keywords Antidepressant Psychotherapist Behavioral activation Clinical psychology Cognition
Key findings Changes in behavioral activation accounted for significant unique variance in depression improvements after an ayahuasca experience, suggesting it is an important mechanism underlying the antidepressant effects.

Abstract

Ayahuasca, a plant-based hallucinogen that serves as a spiritual medicine in South America, has improved depression in at least one placebo-controlled clinical trial. Case studies suggest that dramatic behavioral changes often follow the Ayahuasca ceremony, but most explanations of antidepressant effects focus on observed changes in mindfulness. The present study investigated if both mindfulness and behavioral activation might also contribute to these anti-depressant effects. We surveyed individuals (N = 152) about their changes in depressive symptoms, Behavioral Activation, and mindfulness after an Ayahuasca experience. Mindfulness was strongly associated with reduced depression severity (r = -.670, p < .001), while behavioral activation was moderately linked (r = -.474, p < .001). Changes in depressive symptoms (Center for Epidemiological Sciences Depression Short Form [CES-D-10]) covaried with subscales from the Five Facet Mindfulness Questionnaire [FFMQ] and Experiences Questionnaire [EQ], confirming previous findings (beta = -.57, [95% CI (- 5.70) - (- 3.25)], p < .001). In addition, a modification of the Behavioral Activation for Depression Scale-Short Form [BADS-SF] accounted for significant unique variance in the improvements in depression (beta = -.16, [95% CI (-6.32) - (-0.08)], p < .05). These results suggest that changes in behavioral activation likely serve as an important mechanism underlying Ayahuasca’s antidepressant effects. Future clinical trials could benefit from tracking behavioral activation. In addition, a concerted focus on increasing valued, positive activities might enhance Ayahuasca’s anti-depressant effects.

Comparable studies

Other cross-sectional and survey studies on ayahuasca for anxiety, most cited first.

Study Year Design Participants
Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States. Adults with at least one lifetime psychedelic experience 2022 Cross-sectional survey n = 2,510
Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers People reporting depression or anxiety diagnoses at the time of consuming ayahuasca in... 2021 Cross-sectional survey n = 2,011
The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility English- and German-speaking adults who had a psychedelic experience with LSD,... 2022 Retrospective online survey n = 1,833
Psychosocial and Drug Use Assessment of Regular vs. Non-Regular Ayahuasca Users in a Brazilian Sample: a Web-Based Survey People who use ayahuasca in Brazil 2022 Cross-sectional survey n = 286
Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users Ayahuasca veterans and non-users 2024 Cross-sectional study n = 107

Explore topics

By condition and practice